Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 30/100

Failure Rate

14.8%

50 terminated/withdrawn out of 338 trials

Success Rate

84.8%

-1.8% vs industry average

Late-Stage Pipeline

68%

230 trials in Phase 3/4

Results Transparency

71%

198 of 278 completed trials have results

Key Signals

198 with results42 terminated8 withdrawn

Enrollment Performance

Analytics

Phase 3
122(37.1%)
Phase 4
108(32.8%)
Phase 2
54(16.4%)
Phase 1
23(7.0%)
N/A
21(6.4%)
Early Phase 1
1(0.3%)
329Total
Phase 3(122)
Phase 4(108)
Phase 2(54)
Phase 1(23)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (338)

Showing 20 of 338 trials
NCT01180634Phase 3Completed

MP-376 (Aeroquin™, Levofloxacin for Inhalation) in Patients With Cystic Fibrosis

Role: collaborator

NCT01270347Phase 3Completed

Trial of Aeroquin Versus Tobramycin Inhalation Solution (TIS) in Cystic Fibrosis (CF) Patients

Role: collaborator

NCT01157234Phase 4Completed

Nebivolol Effect on Nitric Oxide Levels, Blood Pressure, and Renal Function in Kidney Transplant Patients

Role: collaborator

NCT01829243Phase 3Completed

Milnacipran and Neurocognition, Pain and Fatigue in Fibromyalgia : A 13-week Randomized, Placebo Controlled Cross Over Trial

Role: collaborator

NCT00646204Phase 4Completed

Namenda (Memantine) for Non-motor Symptoms in Parkinson's Disease

Role: collaborator

NCT01357837Phase 2Completed

Assessment of GRT6005 in Painful Osteoarthritis of the Knee

Role: collaborator

NCT03882762Phase 1Completed

A Clinical Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of Cebranopadol

Role: collaborator

NCT01725087Phase 2Completed

Efficacy and Safety of GRT6005 in Patients With Chronic Low Back Pain.

Role: collaborator

NCT03958123Phase 1Completed

Evaluation of the Effects of Multiple Doses of Cebranopadol on the Electrical Activity of the Heart in Healthy Subjects

Role: collaborator

NCT01709214Phase 2Completed

Safety and Efficacy Study of GRT6005 in Patients With Osteoarthritis (OA) Knee Pain

Role: collaborator

NCT01347671Phase 2Completed

Safety and Efficacy of GRT6005 in Pain Due to Diabetic Polyneuropathy

Role: collaborator

NCT00652457Phase 4Completed

Study of Memantine to Treat Huntington's Disease

Role: collaborator

NCT02559817Phase 2Terminated

A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation

Role: lead

NCT02220348Phase 1Completed

A Lactation Study in Women Who Are Breastfeeding or Pumping and Are Receiving Linaclotide Therapeutically

Role: lead

NCT01858519Completed

Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy

Role: collaborator

NCT00545974Phase 4Completed

Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia

Role: collaborator

NCT02431806Phase 3Completed

Safety and Efficacy of Levomilnacipran ER in Adolescent Participants With Major Depressive Disorder

Role: lead

NCT01288937Phase 3Terminated

A Placebo Controlled, Randomized, Double Blind Trial of Milnacipran for the Treatment of Idiopathic Neuropathy Pain

Role: collaborator

NCT01522950Phase 2Completed

A Study Examining the Effects of Nebivolol Compared to Atenolol on Endothelial Function

Role: collaborator

NCT01401595Phase 3Completed

Brain Imaging and Treatment Studies of the Night Eating Syndrome

Role: collaborator